WelAhead by Welmate Lidocaine 5% Roll-on

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
WelAhead by Welmate Lidocaine 5% Roll-on
Generic name
LIDOCAINE 5%
Manufacturer
OTC PHARM LLC
Product type
HUMAN OTC DRUG
SPL set ID
0b75e83e-8c7b-6247-e063-6294a90ac413
SPL ID
35a93f2b-396d-1532-e063-6394a90a7c83
Version
2
Effective date
2025-05-21
Source export date
2026-09-28
Source partition
10
Source file
https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/4bbc9760f647649b787710953d978bd6419e899ba8b90f32c3d972aae43947f8/drug-label-0010-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 06:09:03
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Do not use on large areas of the body or on cut, irritated or swollen skin on puncture wounds for more than week without consulting a doctor When using this product: use cnly as directed. Read and follow all directions and warnings on this carton do not allow contact with the eyes and mucous membranes do not bandage or apply a local heat (such as heating pads) to the area of use Stop use and aska doctor if condition worsens skin reactions occur, such as rash, itching, redness, irritation, pain, and swelling symptoms persist for more than 7 days or clear up and occur again within a days Flammable keep away from fire or flame If pregnant or breast freding , ask a health professional before use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.